Published on 21 Dec 2023 on Exec Edge via Yahoo Finance
By Healthcare Edge Editorial Staff
Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanjeev Luther as incoming President and Chief Executive Officer from Jan. 1, 2024.
Start tracking your investments with Statfolio
By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanj...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Dr. James Bristol, an...
Quite a few insiders have dramatically grown their holdings in Eterna Therapeutics Inc. (NASDAQ:E...
Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to genera...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) is partnering with Lineage Cell Therape...
By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA), a life science compan...
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA), announced the successful completion of...
Richard Wagner and Brant Binder By Daniella Parra
By Daniella Parra Eterna Therapeutics Inc. (Nasdaq: ERNA) said it named Megan Yung as Chief Strat...
<img alt="" src="https://s.yimg.com/ny/api/res/1.2/UQ4kiCL34cEHt2UZeYR8lg--/YXBwaWQ9aGlnaGxhbmR...